Identification of an Objective Cut-Off Point to Define the Clinical Stage T4a in Colon Cancer

Author:

Bautista-Saiz Carolina1,Rivera-Moncada Luisa F.1,Lino-Silva Leonardo S.1ORCID,Pérez-Correa Guillermo A.1,Frías-Fernández Pedro2

Affiliation:

1. Instituto Nacional de Cancerología (Mexico’s National Cancer Institute), San Fernando 22, Tlalpan, Mexico City 14080, Mexico

2. Hospital General de Tula, Carretera Tula-Tepeji Km 1.5, El Carmen, Tula de Allende 42830, Mexico

Abstract

Introduction: The current state of pathology practice and the variability in diagnosing pT4a colon cancer have been underexplored in existing studies. Our objective was to establish a specific cutoff point to distinguish between the pathological stages of pT3 and pT4a in colon cancer. Methods: We conducted a cross-sectional study involving pT3 and pT4 (pN0-2, cM0) colon cancers, measuring the distance to the serosa. Patients were categorized and analyzed based on this distance and the peritoneal reaction, with the aim being to ascertain their prognostic implications. Results: A total of 384 patients were analyzed. Patients with a distance between the invading front of cancer and the serosa ≥ 1 mm without a peritoneal reaction exhibited a median survival of 118 months, contrasting the amount of 70 months for those with <1 mm plus peritoneal reaction. Only lengths <1 mm with peritoneal reaction showed a significant correlation with mortality (p < 0.001). Conclusion: Our study revealed that patients in whom neoplastic cells were less than 1 mm from the serosal surface, accompanied by a peritoneal reaction (hemorrhage, inflammation, neovascularization, fibrin), had significantly lower survival rates compared to those with more than 1 mm distance and without peritoneal response (70 vs. 118 months, p < 0.001). Hence, such cases should be considered within the pT4a stage.

Publisher

MDPI AG

Reference29 articles.

1. (2023, May 08). World Gastroenterology Organization/International Digestive Cancer Alliance Practice Guidelines: Colorectal Cancer Screening. Available online: http://www.worldgastroenterology.org/assets/downloads/es/pdf/guidelines/cancer_colorectal_tamizaje_screening_y_vigilancia.

2. Cancer statistics, 2023;Siegel;CA Cancer J Clin.,2023

3. Colorectal cancer: Epidemiology, risk factors, and health services;Amersi;Clin. Colon Rectal Surg.,2005

4. Locally advanced colon cancer; current clinical practice and treatment outcome in the Netherlands;Klaver;Color. Dis.,2015

5. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer;Thomassen;Eur. J. Surg. Oncol.,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3